Barrons Medical Journal Interviews Hybrid Pharmaceutical, the Genomics Biotech
Engineering Company, CEO Rose Conrad Ph.D.
The Status Of A Breast Cancer Cure
From MD Anderson Galveston TX, Campus:
Business Wire
Galveston ( AP ) Barrons Medical Journal reports that we are on our way to a breast
cancer cure. We now have the foundation to a Breast Cancer Cure. Leading the way is Genomics. Genomics has a few new partners. Starting the election of President Obama. President Obama Affordable Care Act. Governor Rick Perry dedication in the State Of Texas to provide a platform for any companies that is doing research on stem cells.
Gennxeix Biotech model for detecting breast cancer using their 21 Gene cocktail of genes like P53, P63 and Her-1 to name a few, allows scientist and Doctors to do r
eal–time analysis of a patients breast cancer tumor Perform surgery to remove the tumor and replace to the cell with a stem cell from another part of your body.
Breast cancer is the most common malignancy in United States women, accounting for >40,000 deaths each year. These breast tumors are comprised of phenotypically diverse populations of breast cancer cells. Using a model in which human breast cancer cells were grown in immunocompromised mice,
we found that only a minority of breast cancer cells had the ability to form new tumors. We were able to distinguish the tumorigenic (tumor initiating) from the nontumorigenic cancer cells based on cell surface marker expression
Gennxeix Biotech Breast Cancer Researchers and Scientist are ahead of the curve with technologies based on Nanoparticles and Semi Conductors Namely Genomics and treatments.
Brought To You By gloStream
The field of genomics is caught in a data deluge. Targeted breast cancer DNA sequencing is becoming faster and cheaper at a pace far outstripping Moore’s law, which describes the rate at which computing gets faster and cheaper.
The result is that the ability to determine Targeted breast cancer DNA sequences is starting to outrun the ability of researchers to store, transmit and especially to analyze the data.
The cost of sequencing a human genome — all three billion bases of DNA in a set of human chromosomes — plunged to $10,000.00 which means genomics breast cancer DNA sequencing is around $3000.00.
The lower cost, along with increasing speed, has led to a huge increase in how much breast Cancer sequencing data is being produced.
Numerous investigations have shown that both tissue and cell distribution profiles can be controlled by their entrapment in submicronic colloidal systems (nanoparticles). The rationale behind this approach is to increase antitumor efficacy, while reducing systemic side-effects. This review provides an update of tumor targeting with conventional or long-circulating nanoparticles. The in vivo fate of these systems,
after intravascular or tumoral administration, is discussed, as well as the mechanism involved in tumor regression. Nanoparticles are also of benefit for the selective delivery of oligonucleotides to tumor cells. Moreover, certain types of nanoparticles showed some interesting capacity to reverse MDR resistance, which is a major problem in chemotherapy. The first experiments, aiming to decorate nanoparticles with molecular ligand for active targeting of cancerous cells
Miniaturization will allow the tools for many different tests to be situated together on the same small device. Gennxeix Biotech Researchers Say that nanotechnology will allow them to run many diagnostic tests simultaneously.
Nanoparticles nanoshells is use to antibodies that recognize cancer cells. GenNxeix scientist envisions letting these nanoshells seek out their cancerous targets, then applying near-infrared light. The heat generated by the light-absorbing nanoshells can successfully killed breast cancer tumor cells while leaving neighboring cells intact.
A nanometer is a billionth of a meter. It's difficult to imagine anything so small, but think of something only 1/80,000 the width of a human hair. Ten hydrogen atoms side-by-side in a single nanometer.
GenNxeix minuscule molecule that will be used to detect breast cancer is a quantum dot. Quantum dots are tiny crystals that glow when they are stimulated by ultraviolet light. The wavelength, or color, of the light depends on the size of the crystal. Latex beads filled with these crystals can be designed to bind to specific DNA sequences.
Gennxeix Biotech understands that Hyperthermia gold nanoshell Targeted breast cancer genomics at 40 for high risk women will reduce breast cancer at 60 years of Age. Training Genomics Counselor and Storing DNA Analysis in the cloud will allow Gennxeix Biotech to say that Chemotherapy will help their breast cancer outcome or if Chemotheraphy and Hyperthermia will extend their life.
Governor Rick Perry Texas' top ranking in the creation of biotech jobs, another sign that the Lone Star State is the place where high-tech visionaries of all types are planting their flags. However, very few of these fields are more promising, or important, than this one.
Adult stem cell research can change the world through regenerative medicine and its untapped potential to tackle some of the most challenging diseases known to man.
GenNXeix Biotech Analytics Research has shown genomics, pluripotent stem (iPS) cells is the Future for Treating Breast Cancer along with Bacteria process called quorum sensing. Pluripotency (from the Latin plurimus, meaning very many, and potens, meaning having power) refers to a stem cell that has the potential to differentiate into any of the t
hree germ layers: endoderm (interior stomach lining, gastrointestinal tract, the lungs), mesoderm (muscle, bone, blood, urogenital), or ectoderm (epidermal tissues and nervous system). Bacteria communicate with one another using chemical signal molecules. As in higher organisms, the information supplied by these molecules is critical for synchronizing the activities of large groups of cells. In bacteria, chemical communication involves producing, releasing, detecting, and responding to small hormone-like molecules termed auto inducers. This process, termed quorum sensing, allows bacteria to monitor the environment for other bacteria and to alter behavior on a population-wide scale in response to changes in the number and/or species present in a community. Most quorumsensing-controlled processes are unproductive when undertaken by an individual bacterium acting alone but become beneficial when carried out simultaneously by a large number of cells. Thus, quorum sensing confuses the distinction between prokaryotes and eukaryotes because it enables bacteria to act as multicellular organisms. This review focuses on the architectures of bacterial chemical communication networks; how chemical information is integrated, processed, and transduced to control gene expression; how intra- and interspecies cell-cell communication is accomplished; and the intriguing possibility of prokaryote-eukaryote cross-communication. They Final Key Bipartisn policy that President Obama and Governor Rick Perry agrees on is Electronic Medical Records. Gennxeix Medical System Announced Today Outsourcing of Electronic Medical Records from your location Doctors. Gennxeix The purpose of the GenNXeix Medical System Electronic Medical Record ("EHR") Service Level Agreement ("SLA") is to formalize our commitment to our valued health care professional users ("Clients"). Our SLA is intended to memorialize the specific level of support that we promise to provide to our Clients. This SLA may evolve over time, with additional knowledge of our Clients requirements, as well as the introduction of new application and services into the support portfolio, so please continue to check back for updates. ________________________________________ Definitions The following definitions shall apply to the GenNXeix Medical System EHR SLA. "Downtime" means, for the EHR, if there is more than a five percent (5%) of the user community issue rate. Downtime is measured based on server side issue rate. "Downtime Period" means, for the EHR, a period of ten consecutive minutes of Downtime. Intermittent Downtime for a period of less than ten minutes will not be counted towards any Downtime Periods. ________________________________________ "GenNXeix Medical System EHR Covered Services" means the GenNXeix Medical System Electronic Medical Record and Practice Management Service. This does not include the GenNXeix Medical System website, support site, or any other additional Gennxeix Medical Systems, Inc. branded site that does not pertain directly to the EHR system.
"Monthly Uptime Percentage" means total number of minutes in a calendar month minus the number of minutes of Downtime suffered from all Downtime Periods in a calendar month, divided by the total number of minutes in a calendar month. "Scheduled Downtime" means those times where Gennxeix Medical Systems, Inc. notifies Client of periods of Downtime at least twenty four hours prior to the commencement of such Downtime. There will be no more than thirty-six hours of Scheduled Downtime per calendar year. Scheduled Downtime is not considered Downtime for purposes of this GenNXeix Medical System EHR SLA, and will not be counted towards any Downtime Periods.
